Compare RNA & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | IPAR |
|---|---|---|
| Founded | 2012 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 2.6B |
| IPO Year | 2020 | 1988 |
| Metric | RNA | IPAR |
|---|---|---|
| Price | $71.76 | $82.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 5 |
| Target Price | $69.26 | ★ $128.20 |
| AVG Volume (30 Days) | ★ 2.9M | 286.0K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 3.87% |
| EPS Growth | N/A | ★ 9.68 |
| EPS | N/A | ★ 5.13 |
| Revenue | $20,868,000.00 | ★ $1,463,838,000.00 |
| Revenue This Year | $64.11 | $3.42 |
| Revenue Next Year | $37.25 | $1.53 |
| P/E Ratio | ★ N/A | $16.15 |
| Revenue Growth | ★ 106.27 | 3.12 |
| 52 Week Low | $21.51 | $77.21 |
| 52 Week High | $71.79 | $148.15 |
| Indicator | RNA | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 77.56 | 39.99 |
| Support Level | $71.42 | $79.50 |
| Resistance Level | $71.76 | $82.10 |
| Average True Range (ATR) | 0.41 | 2.76 |
| MACD | -0.73 | 0.54 |
| Stochastic Oscillator | 88.32 | 53.57 |
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.